We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VMC:NYSEVulcan Materials Company (Holding Company) Analysis

Data as of 2026-09-09 - not real-time

$249.89

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Vulcan Materials Company is bearish at $249.89, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 13.4%. With RSI at 30.6 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $249.52 and resistance around $288.40.
The shares look fair at 29.5 times earnings, though no sector average was available for comparison. Consensus targets land 30.4% above where the shares trade now. Revenue is growing at 2.5% on a 13.7% profit margin. The 0.81% dividend yield looks covered by current payout levels.
Risk scores 5 out of 10, which is moderate for this asset class. With 30-day volatility of 32.1%, a beta of 0.80 and a maximum drawdown of 24.4%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 2/10 long-term conviction.

Top Market Events

Despite significant energy headwinds, Vulcan Materials Co VMC maintained strong financials with strategic acquisitions...Vulcan Materials stock trades around $270 in August 2026 after beating Q2 2026 earnings expectationsConstruction materials company Vulcan Materials NYSE:VMC reported Q2 CY2026 results , with sales up 2.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 288.10
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 288.10
  • Analyst targets imply +30.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +30.4% versus the current price
  • P/E ratio of 29.5
  • Dividend yield of 0.81%

Key Metrics & Analysis

Financial Health

Revenue Growth2.50%
Profit Margin13.75%
P/E Ratio29.5
ROE13.23%
ROA6.04%
Debt/Equity58.22
P/B Ratio3.8
Op. Cash Flow$1.8B
Free Cash Flow$843.6M

Technical Analysis

TrendBearish
RSI30.6
Support$249.52
Resistance$288.40
MA 20$270.45
MA 50$280.29
MA 200$288.10
MACDBearish
VolumeIncreasing
Fear & Greed Index92.04

Valuation

Fair Value$54.77
Target Price$325.74
Upside/Downside30.35%
GradeFair
TypeBlend
Dividend Yield0.81%

Risk Assessment

Beta0.80
Volatility32.13%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.